A detailed history of Livelsberger Financial Advisory transactions in Pfizer Inc stock. As of the latest transaction made, Livelsberger Financial Advisory holds 4,278 shares of PFE stock, worth $112,768. This represents 2.6% of its overall portfolio holdings.

Number of Shares
4,278
Holding current value
$112,768
% of portfolio
2.6%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$27.7 - $31.39 $118,500 - $134,286
4,278 New
4,278 $124 Million
Q4 2023

Mar 22, 2024

BUY
$26.13 - $33.94 $107,211 - $139,255
4,103 New
4,103 $118 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Livelsberger Financial Advisory Portfolio

Follow Livelsberger Financial Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Livelsberger Financial Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Livelsberger Financial Advisory with notifications on news.